You are here: Home » PTI Stories » National » News
Business Standard

Zydus Cadila gets USFDA nod for blood pressure lowering drug

Press Trust of India  |  New Delhi 

Drug firm Monday said it has received final nod from the US health regulator to market tablets, used to treat

has received the final approval from the Food and Drug Administration (USFDA) to market tablets in the strengths of 25 mg and 50 mg, the company said in a BSE filing.

is used to treat (hypertension). It is also used to treat fluid retention (edema) in people with congestive heart failure, of the liver or or edema caused by taking steroids or estrogen.

said the product will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The group now has 266 approvals and has filed over 350 abbreviated new drug applications (ANDAs) since the commencement of its filing process, Zydus Cadila said.

Shares of Cadila Healthcare, the listed entity of the group, were trading 3.02 per cent lower at Rs 280.95 apiece on BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, May 13 2019. 11:20 IST